PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.\', \'Chungbuk National University College of Medicine, Cheongju, South Korea.\', \'Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.\', \'Hallym University Sacred Heart Hospital, Anyang-si, South Korea.\', \'Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.\', \'National Cancer Center, Seoul, South Korea.\', \'Seoul National University Boramae Medical Center, Seoul, South Korea.\', \'Sungkyunkwan University Samsung Medical Center, Seoul, South Korea.\', \'Chonbuk National University Medical School, Jeonju, South Korea.\', \'Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea.\', \'Korea University Anam Hospital, Seoul, South Korea.\', \'Gangnam Severance Hospital, Seoul, South Korea.\', \'Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea. bangyj@snu.ac.kr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10120-019-00958-4
?:hasPublicationType
?:journal
  • Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
is ?:pmid of
?:pmid
?:pmid
  • 30945121
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer.
?:type
?:year
  • 2019

Metadata

Anon_0  
expand all